GENB institutional holders
GENERATE BIOMEDICINES INC · 13F, 2026Q2
| Managers holding | 86 |
|---|
| Shares held | 100,045,749 |
|---|
| Reported value | $1.7bn |
|---|
| Quarter flows | 42 new, 24 added, 10 trimmed, 13 exited |
|---|
Top 25 holders
| Manager | Shares | Value | % of manager's 13F |
|---|
| Flagship Pioneering, LLC | 62,673,117 | $1.1bn | 68.7% |
| FMR LLC | 5,221,599 | $88.1m | 0.0% |
| Capital World Investors | 4,215,632 | $71.1m | 0.0% |
| BRAIDWELL LP | 3,283,844 | $55.4m | 2.0% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,156,627 | $36.4m | 0.0% |
| NORGES BANK | 2,094,616 | $35.3m | 0.0% |
| ARCH Venture Management, LLC | 1,944,426 | $32.8m | 3.0% |
| HarbourVest Partners LLC | 1,722,210 | $29.1m | 17.1% |
| BlackRock, Inc. | 1,659,966 | $28.0m | 0.0% |
| BAKER BROS. ADVISORS LP | 1,423,602 | $24.0m | 0.1% |
| JPMORGAN CHASE & CO | 1,409,649 | $23.8m | 0.0% |
| Deep Track Capital, LP | 1,333,815 | $22.5m | 0.3% |
| ARK Investment Management LLC | 1,284,617 | $21.7m | 0.1% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,132,750 | $19.1m | 0.0% |
| HARVARD MANAGEMENT CO INC | 1,111,100 | $18.7m | 0.4% |
| NVIDIA CORP | 833,325 | $14.1m | 0.0% |
| Davern Capital Partners, LP | 824,679 | $13.9m | 2.4% |
| Siren, L.L.C. | 736,104 | $12.4m | 0.3% |
| GEODE CAPITAL MANAGEMENT, LLC | 735,003 | $12.4m | 0.0% |
| STATE STREET CORP | 526,565 | $8.9m | 0.0% |
| Affinity Asset Advisors, LLC | 400,000 | $6.7m | 0.3% |
| MORGAN STANLEY | 377,994 | $6.4m | 0.0% |
| UBS Group AG | 326,273 | $5.5m | 0.0% |
| SPHERA FUNDS MANAGEMENT LTD. | 245,000 | $4.1m | 0.5% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 224,602 | $3.8m | 0.0% |
Every holder, line by line, and the full history since 2013: yf.Client().holders("GENB"). GENB price history · All 13F data
Get a free API keySee history bundlesDownload free samples